journal article·2025-11-28Open access

Tumor accumulation in polyethylene glycol-modified dendrimers with enhanced hydration

Hao He, Junjie Yao, Agus Kubo, Ayako Tsujimoto, Yuka Ikemoto, Akikazu Matsumoto, Chie Kojima

NPG Asia Materials· Volume 17· Issue 1

Abstract

Hydration of materials affects their antifouling properties, and polyethylene glycol (PEG) is highly hydrated and biocompatible. PEGylated dendrimers have been studied as drug carriers that passively accumulate in tumors owing to their enhanced permeability and retention effect. In this study, we synthesized various PEGylated dendrimers with different PEG molecular weights, bound numbers, and dendrimer generations, and analyzed their hydration properties using differential scanning calorimetry and Fourier transform infrared spectroscopy. Intermediate water is defined as water molecules loosely bound to a material, the amount of which has been reported to be a useful index of bioinert properties. The amount of intermediate water was estimated from enthalpy change in melting peaks below 0 °C, considering a PEG-water eutectic system. Our results indicate that intermediate water was richer in PEGylated dendrimers with longer and more PEG chains. These PEGylated dendrimers, with longer and more PEG chains, also showed enhanced tumor accumulation after intravenous injection. The tumor-to-liver ratio correlated with the intermediate water content in the PEGylated dendrimers. This suggests that hydration is an important factor influencing dendrimer biodistribution, which is a possible criterion in designing nanocarriers for drug delivery systems. Researchers are exploring ways to improve drug delivery systems (DDS) to make cancer treatments more effective and reduce side effects. This study investigates how the structure of these nanoparticles affects their ability to deliver to tumor tissues. Researchers focused on PEGylated dendrimers, which are nanoparticles coated with polyethylene glycol (PEG). They created different versions of these dendrimers by varying the length and number of PEG chains. They then studied how these changes affected the nanoparticles’ hydration and distribution in the body. Using techniques like differential scanning calorimetry (DSC) and infrared spectroscopy, they measured how much water the dendrimers could hold. They found that longer PEG chains and higher PEG densities increased the intermediate water moderately interacted with materials, which improved the nanoparticles’ ability to reach tumors. The study concludes that hydration is an important factor in biodistribution, which is a possible criterion in designing nanocarriers. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author. In this study, polyethylene glycol (PEG)-modified dendrimers with different PEG molecular weights and PEG bound ratios were synthesized. Because the amount of intermediate water, which moderately interacts with materials, is known to be related to biocompatibility, we investigated the hydration and biodistribution of PEG-modified dendrimers with different structures. Dendrimers modified with longer and denser PEG chains had higher intermediate water content (WIM) and showed an increased tumor/liver ratio after the intravenous injection. These findings highlight hydration as a key physicochemical factor governing biodistribution, which is useful for optimizing nanocarriers in drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Maruyama, K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug Deliv. Rev. 63, 161–169 (2011).10.1016/j.addr.2010.09.003 ↗
2. Wicki, A., Witzigmann, D., Balasubramanian, V. & Huwyler, J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J. Control. Release 200, 138–157 (2015).10.1016/j.jconrel.2014.12.030 ↗
3. Beach, M. A. et al. Polymeric nanoparticles for drug delivery. Chem. Rev. 124, 5505–5616 (2024).10.1021/acs.chemrev.3c00705 ↗
4. Fang, J., Nakamura, H. & Maeda, H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63, 136–151 (2011).10.1016/j.addr.2010.04.009 ↗
5. Mishra, P., Nayak, B. & Dey, R. K. PEGylation in anti-cancer therapy: an overview. Asian J. Pharm. Sci. 11, 337–348 (2016).
6. Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28–51 (2016).10.1016/j.addr.2015.09.012 ↗
7. Yang, Q. et al. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. Mol. Pharm. 11, 1250–1258 (2014).10.1021/mp400703d ↗
8. Li, Q. et al. Zwitterionic biomaterials. Chem. Rev. 122, 17073–17154 (2022).10.1021/acs.chemrev.2c00344 ↗
9. Bag, M. A. & Valenzuela, L. M. Impact of the hydration states of polymers on their hemocompatibility for medical applications: a review. Int. J. Mol. Sci. 18, 1422 (2017).10.3390/ijms18081422 ↗
10. Chen, S., Li, L., Zhao, C. & Zheng, J. Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer 51, 5283–5293 (2010).10.1016/j.polymer.2010.08.022 ↗
11. Tanaka, M., Hayashi, T. & Morita, S. The roles of water molecules at the biointerface of medical polymers. Polym. J. 45, 701–710 (2013).10.1038/pj.2012.229 ↗
12. Tanaka, M., Morita, S. & Hayashi, T. Role of interfacial water in determining the interactions of proteins and cells with hydrated materials. Colloids Surf. B 198, 111449 (2021).10.1016/j.colsurfb.2020.111449 ↗
13. Kojima, C. et al. Hydration and biodistribution of zwitterionic dendrimers conjugating a sulfobetaine monomer and polymers. Langmuir 41, 1411–1417 (2025).10.1021/acs.langmuir.4c04276 ↗
14. Hatakeyama, T., Kasuga, H., Tanaka, M. & Hatakeyama, H. Cold crystallization of poly(ethylene glycol)–water systems. Thermochim. Acta 465, 59–66 (2007).10.1016/j.tca.2007.09.005 ↗
15. Huang, L. & Nishinari, K. Interaction between poly(ethylene glycol) and water as studied by differential scanning calorimetry. J. Polym. Sci. B 39, 496–506 (2001).10.1002/1099-0488(20010301)39:5<496::AID-POLB1023>3.0.CO;2-H ↗
16. Kuttich, B., Matt, A., Appel, C. & Stühn, B. X-ray scattering study on the crystalline and semi-crystalline structure of water/PEG mixtures in their eutectic phase diagram. Soft Matter 16, 10260–10267 (2020).10.1039/D0SM01601B ↗
17. Gemmei-Ide, M., Motonaga, T., Kasai, R. & Kitano, H. Two-step recrystallization of water in concentrated aqueous solution of poly(ethylene glycol). J. Phys. Chem. B 117, 2188–2194 (2013).10.1021/jp3102628 ↗
18. Kojima, C., Suzuki, Y., Ikemoto, Y., Tanaka, M. & Matsumoto, A. Comparative study of PEG and PEGylated dendrimers in their eutectic mixtures with water analyzed using X-ray diffraction and infrared spectroscopy. Polym. J. 55, 63–73 (2023).10.1038/s41428-022-00700-5 ↗
19. Tsujimoto, A. et al. Different hydration states and passive tumor targeting ability of polyethylene glycol-modified dendrimers with high and low PEG density. Mater. Sci. Eng. C 126, 112159 (2021).10.1016/j.msec.2021.112159 ↗
20. Tomalia, D. A. Dendrimers, dendrons, and the dendritic state: Reflection on the last decade with expected new roles in pharma, medicine, and the life sciences. Pharmaceutics 16, 1530 (2024).10.3390/pharmaceutics16121530 ↗
21. Svenson, S. & Tomalia, D. A. Dendrimers in biomedical applications—reflections on the field. Adv. Drug Deliv. Rev. 57, 2106–2129 (2005).10.1016/j.addr.2005.09.018 ↗
22. Kaminskas, L. M., Boyd, B. J. & Porter, C. J. H. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine 6, 1063–1084 (2011).10.2217/nnm.11.67 ↗
23. Shiba, H. et al. Carbox-terminal dendrimers with phenylalanine for a pH-sensitive delivery system into immune cells including T cells. J. Mater. Chem. B 10, 2463–2470 (2022).10.1039/D1TB01980E ↗
24. Sonoda, T., Kobayashi, S., Herai, K. & Tanaka, M. Side-chain spacing control of derivatives of poly(2-methoxyethyl acrylate): impact on hydration states and antithrombogenicity. Macromolecules 53, 8570–8580 (2020).10.1021/acs.macromol.0c01144 ↗
25. Ruggeri, F. et al. The dendrimer impact on vesicles can be tuned based on the lipid bilayer charge and the presence of albumin. Soft Matter 9, 8862–8870 (2013).10.1039/C3SM50603G ↗
26. Kojima, C., Regino, C., Umeda, Y., Kobayashi, H. & Kono, K. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Int. J. Pharm. 383, 293–296 (2010).10.1016/j.ijpharm.2009.09.015 ↗
27. Fox, M. E., Szoka, F. C. & Fréchet, J. M. J. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc. Chem. Res. 42, 1141–1151 (2009).10.1021/ar900035f ↗
28. Annunziata, O. et al. Effect of polyethylene glycol on the liquid–liquid phase transition in aqueous protein solutions. Proc. Natl. Acad. Sci. USA 99, 14165–14170 (2002).10.1073/pnas.212507199 ↗
29. Derkaoui, N., Said, S., Grohens, Y., Olier, R. & Privat, M. PEG400 novel phase description in water. J. Colloid Interface Sci. 305, 330–338 (2007).10.1016/j.jcis.2006.10.008 ↗
30. Morita, S., Tanaka, M. & Ozaki, Y. Time-resolved in situ ATR-IR observations of the process of sorption of water into a poly(2-methoxyethyl acrylate) film. Langmuir 23, 3750–3761 (2007).10.1021/la0625998 ↗
31. Li, H. et al. The protein corona and its effects on nanoparticle-based drug delivery systems. Acta Biomater. 129, 57–72 (2021).10.1016/j.actbio.2021.05.019 ↗
32. Hofheinz, F. et al. An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res. 6, 19 (2016).10.1186/s13550-016-0174-y ↗